Google image

Google partners with AbbVie on ageing

September 4, 2014
Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google

Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …

icon_spectre

ICON appoints vice president from Allergan

September 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, ira spector

Healthcare outsourced development firm ICON has hired Dr Ira Spector to be the executive vice president of its analytics and …

Solaris image

NICE backs world’s most expensive medicine

September 4, 2014
Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris

In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …

Brilinta image

Mixed results for AZ’s troubled Brilinta

September 3, 2014
Sales and Marketing AstraZeneca, Brilinta, EMA, PCI, atlantic, heart, stent

The latest trial for AstraZeneca’s heart drug Brilinta (ticagrelor) has failed to meet expected results but suggests more flexible applications …

Should patients be able to email their general practitioner?

September 3, 2014
Medical Communications, Sales and Marketing BMJ, GPs, clinicians, econsultations, email

Email consultations with your doctor make better use of their time and are more convenient, or threaten safety and create …

BioData appoints new chief executive

September 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Louis Culot, biodata, culot

Digital science portfolio firm BioData that produces web-based research and lab management service Labguru, has appointed Louis Culot as its …

Haslam image

NICE: Cancer Drugs Fund must use our processes

September 3, 2014
Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …

Novo Nordisk image

Novo Nordisk scraps inflammatory disorders business

September 2, 2014
Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen

A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …

Fishawack opens US office in San Francisco

September 2, 2014
Medical Communications US, comms, communications, fishawack, san francisco

Medical communications firm Fishawack has opened a new office in San Francisco in the US. Under its flagship Fishawack Communications brand …

marie-agnes_heine

EMA hires head of comms and HR

September 2, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Manuel Ortigão, Marie-Agnes Heine

The European Medicines Agency has confirmed two new appointments to join its management team.  Marie-Agnes Heine (pictured) has joined to …

Cancer image

Children’s cancer death rates drop

September 2, 2014
Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates

The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …

Ben Venue image

Ben Venue problems continue for Boehringer

September 2, 2014
Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, fad, german, manufacturing, recall

Boehringer Ingelheim’s tribulations at its US production site Ben Venue Laboratories are refusing to leave as more of its products …

sierk-poetting

BioNTech appoints chief financial officer

September 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNTech, Sierk Pötting

German biopharma firm BioNTech has announced that Sierk Pötting will be joining its management team as its chief financial officer, …

Ashya King image

NHS proton beam therapy refusal led to child patient disappearance

September 1, 2014
Sales and Marketing Ashya King, Cancer, NHS, proton beam

The parents of child cancer patient Ashya King say they took him from hospital because NHS doctors would not offer …

astrazeneca_sign_sky_14

AZ shares climb on positive cancer drug news

September 1, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1

AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …

China: a dangerous game that pharma must play

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt

Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …

Novartis heart drug sees stellar results

September 1, 2014
Sales and Marketing Diovan, LCZ696, Novartis, failure, heart, valsartan

Novartis’ new heart pill has produced stellar results in helping patients with heart failure live longer, making it the first …

donald_johns_biogen_idec

Biogen Idec hires from Novartis to head ALS

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …

Jane Griffiths, company group chairman for Janssen EMEA and chairwoman of the EF

Janssen: why transparency is essential to the health of our industry

August 29, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

Trials image

Publish all clinical trials, say pharma doctors

August 29, 2014
Research and Development, Sales and Marketing Goldacre, all trials, data, fpm, transparency

All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …

The Gateway to Local Adoption Series

Latest content